|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Alcoholism | |||||
| Depression | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Depressive Disorder | |||||
| 3 | More general conditions related to this trial | ||||
| Alcohol-Related Disorders | |||||
| Behavioral Symptoms | |||||
| Disorders of Environmental Origin | |||||
| Mental Disorders | |||||
| Mood Disorders | |||||
| Substance-Related Disorders | |||||
| 4 | Interventions listed in this trial | ||||
| naltrexone (Revia) | |||||
| sertraline (Zoloft) | |||||
| Placebo | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Sertraline | |||||
| 6 | More general drug interventions related to this trial | ||||
| Antidepressive Agents | |||||
| Central Nervous System Agents | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Neurotransmitter Agents | |||||
| Neurotransmitter Uptake Inhibitors | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Psychotropic Drugs | |||||
| Serotonin Agents | |||||
| Serotonin Uptake Inhibitors | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| National Institute on Alcohol Abuse and Alcoholism (NIAAA) | |||||